Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

During the COVID-19 pandemic, when fentanyl overdoses surged, doctors were desperate to find ways of helping their patients.

Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...

A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

A novel use of a common treatment for opioid addiction might not be as effective as first believed, according to a recently published study authored by doctors at UCSF and the San Francisco Department ...

The money could benefit the 14 syringe service programs across the five boroughs that offer harm reduction services.

As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes ...

Pat George, chairman of the Kansas Fights Addiction Act Grant Review Board, gives an update to the Senate Ways and Means ...

It has been 30 years since the Food and Drug Administration approved the opioid OxyContin for the treatment of chronic pain. The crisis that ensued is dizzying in its reach and scope, but there is ...

Whatcom County Health and Community Services has partnered with the Swinomish tribe’s didgʷálič Wellness Center to bring a ...

Texas and 14 other states have secured a $7.4 billion settlement from the Sackler family and their company, Purdue Pharma, ...